
Consider diversified exposure to AI model developers and semiconductors as long-term themes, while favoring companies that prioritize safety, monitoring, and alignment; no specific tickers or targets are provided. Treat AI-driven biomedicine and longevity as speculative, long-term opportunities rather than near-term trades. For autonomous driving and obesity treatments such as Ozempic, weigh real-world adoption barriers alongside the technology’s potential.

By Andreessen Horowitz
The a16z Podcast discusses tech and culture trends, news, and the future – especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This podcast is produced by Andreessen Horowitz (aka “a16z”), a Silicon Valley-based venture capital firm. Multiple episodes are released every week; visit a16z.com for more details and to sign up for our newsletters and other content as well!